Drug Name |
Drug ID |
Indication |
Formulation Name |
Formulation ID |
Alectinib
|
DMP1I6Y
|
Lung cancer [2C25.0] |
Alectinib Hydrochloride eq 150mg base capsule |
F23327
|
Aliskiren
|
DM1BV7W
|
Hypertension [BA00-BA04] |
Aliskiren Hemifumarate eq 150mg base tablet |
F23935
|
Alogliptin
|
DM8WI3R
|
Type-2 diabetes [5A11] |
Alogliptin Benzoate eq 6.25mg base tablet |
F23937
|
Alpelisib
|
DMEXMYK
|
Breast cancer [2C60-2C65] |
Alpelisib 50mg tablet |
F24013
|
Baricitinib
|
DM4ONW5
|
Rheumatoid arthritis [FA20] |
Baricitinib 1 mg tablet |
F24020
|
Bisoprolol
|
DM3UZ95
|
Hypertension [BA00-BA04] |
Bisoprolol Fumarate 5mg tablet |
F23385
|
Bosutinib
|
DMTI8YE
|
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive [] |
Bosutinib Monohydrate eq 400mg base tablet |
F23389
|
Cabozantinib
|
DMIYDT4
|
Medullary thyroid gland carcinoma [] |
Cabozantinib S-Malate eq 80mg base capsule |
F23394
|
Capmatinib
|
DMYCXKL
|
Non-small-cell lung cancer [2C25.Y] |
Capmatinib eq 150mg base tablet |
F23099
|
Cholic Acid
|
DM7OKQV
|
Cholelithiasis [DC11] |
Cholic Acid 50mg capsule |
F23679
|
Clofazimine
|
DMEBOFW
|
Crohn disease [DD70] |
Clofazimine 100mg capsule |
F23118
|
Dabrafenib
|
DMX6OE3
|
Melanoma [2C30] |
Dabrafenib Mesylate eq 50mg base capsule |
F23952
|
Elagolix sodium
|
DMRDUC0
|
Endometriosis [GA10] |
Elagolix Sodium 200 mg tablet |
F23730
|
Eltrombopag
|
DMOGFIX
|
Thrombocytopenia [3B64] |
Eltrombopag Olamine eq 75mg acid tablet |
F23440
|
Enzalutamide
|
DMGL19D
|
Prostate cancer [2C82.0] |
Enzalutamide 40mg tablet |
F24056
|
Eprosartan
|
DM07K2I
|
Hypertension [BA00-BA04] |
Eprosartan Mesylate eq 400mg base tablet |
F23443
|
Fedratinib
|
DM4ZBK6
|
Myelofibrosis [2A20.2] |
Fedratinib 100 mg capsule |
F23165
|
Fenoprofen
|
DML5VQ0
|
Osteoarthritis [FA00-FA05] |
Fenoprofen Calcium eq 200mg base capsule |
F23448
|
Fexofenadine
|
DM17ONX
|
Allergic rhinitis [CA08.0] |
Fexofenadine Hydrochloride 180mg tablet |
F23449
|
Fostamatinib
|
DM6AUHV
|
Immune thrombocytopenic purpura [3B64.13] |
Fostamatinib 100 mg tablet |
F24308
|
Fostemsavir
|
DM50ILT
|
Human immunodeficiency virus infection [1C62] |
Fostemsavir 600mg Extended-Release tablet |
F23173
|
Ibrutinib
|
DMHZCPO
|
Mantle cell lymphoma [2A85.5] |
Ibrutinib 280mg tablet |
F23772
|
IPI-145
|
DMWA24P
|
Follicular lymphoma [2A80] |
Duvelisib 15 mg capsule |
F24050
|
Istradefylline
|
DM20VSK
|
Parkinson disease [8A00.0] |
Istradefylline 20 mg tablet |
F23204
|
Ivabradine
|
DM0L594
|
Angina pectoris [BA40] |
Ivabradine Hydrochloride eq 5mg base tablet |
F23963
|
Lasmiditan
|
DMXLVDT
|
Migraine [8A80] |
Lasmiditan 100 mg tablet |
F23800
|
LGX818
|
DMNQXV8
|
Melanoma [2C30] |
Encorafenib 75 mg capsule |
F23152
|
Linagliptin
|
DMWFJTR
|
Non-insulin dependent diabetes [5A11] |
Linagliptin 5mg tablet |
F23211
|
Lonafarnib
|
DMGM2Z6
|
Hutchinson-Gilford progeria syndrome [LD2B] |
Lonafarnib 50 mg capsule |
F24392
|
Lorcaserin
|
DMG6OYJ
|
Obesity [5B81] |
Lorcaserin Hydrochloride 20mg tablet |
F23473
|
Lorlatinib
|
DMICDLV
|
Non-small-cell lung cancer [2C25.Y] |
Lorlatinib 100 mg tablet |
F24310
|
Lusutrombopag
|
DMH6IKO
|
Thrombocytopenia [3B64] |
Lusutrombopag 3 mg tablet |
F23221
|
Mirabegron
|
DMS1GYT
|
Overactive bladder [GC50.0] |
Mirabegron 25mg extended release tablet |
F23822
|
Moexipril
|
DM26E4B
|
Hypertension [BA00-BA04] |
Moexipril Hydrochloride 7.5mg tablet |
F23486
|
Naloxegol
|
DML0B41
|
Opioid-induced constipation [DB32.1] |
Naloxegol Oxalate eq 12.5mg base tablet |
F23971
|
Naltrexone
|
DMUL45H
|
Alcohol dependence [6C40.2] |
Naltrexone Hydrochloride 50mg tablet |
F23492
|
Nilotinib
|
DM7HXWT
|
Chronic myelogenous leukaemia [2A20.0] |
Nilotinib Hydrochloride Monohydrate eq 50mg base capsule |
F23493
|
Osilodrostat
|
DMIJC9X
|
Cushing disease [5A70] |
Osilodrostat eq 10mg base tablet |
F23849
|
Osimertinib
|
DMRJLAT
|
Non-small-cell lung cancer [2C25.Y] |
Osimertinib Mesylate eq 40mg base tablet |
F23977
|
Ozanimod
|
DMT6AM2
|
Multiple sclerosis [8A40] |
Ozanimod 0.23 mg capsule |
F24103
|
Panobinostat
|
DM58WKG
|
Chronic graft versus host disease [] |
Panobinostat Lactate eq 15mg base capsule |
F23505
|
Paroxetine
|
DM5PVQE
|
Anxiety disorder [6B00-6B0Z] |
Paroxetine Hydrochloride eq 12.5mg base extended release tablet |
F23507
|
PF-04449913
|
DMSB068
|
Chronic myelomonocytic leukaemia [2A40] |
Glasdegib 100 mg tablet |
F24309
|
Pimavanserin
|
DMR7IVC
|
Parkinson disease [8A00.0] |
Pimavanserin Tartrate 10 mg tablet |
F23516
|
Prasugrel
|
DM7MT6E
|
Acute coronary syndrome [BA41] |
Prasugrel Hydrochloride eq 10mg base tablet |
F23518
|
Quinapril
|
DMR8H31
|
Chronic heart failure [BD1Z] |
Quinapril Hydrochloride eq 10mg base tablet |
F24436
|
R0-93877
|
DMM4U9G
|
Constipation [DD91.1] |
Prucalopride 2 mg tablet |
F23875
|
Raltegravir
|
DMYURI6
|
Human immunodeficiency virus infection [1C62] |
Raltegravir Potassium eq 25mg base Chewable tablet |
F23529
|
Relugolix
|
DMK7IWL
|
Prostate cancer [2C82.0] |
Relugolix 120 mg tablet |
F23267
|
Ribociclib Succinate
|
DM9CIUW
|
Breast cancer [2C60-2C65] |
Ribociclib Succinate 200mg tablet |
F23272
|
Safinamide
|
DM0YWJC
|
Parkinson disease [8A00.0] |
Safinamide Mesylate 100 mg tablet |
F24312
|
Saquinavir
|
DMG814N
|
Human immunodeficiency virus infection [1C62] |
Saquinavir Mesylate eq 200mg base capsule |
F23546
|
Siponimod
|
DM2R86O
|
Multiple sclerosis [8A40] |
Siponimod 0.25mg tablet |
F23895
|
Sumatriptan
|
DMVYXR8
|
Cluster headache [8A81.0] |
Sumatriptan Succinate eq 25mg base tablet |
F23552
|
Tafenoquine
|
DM1XT4N
|
Malaria [1F40-1F45] |
Tafenoquine 150 mg tablet |
F23913
|
Talazoparib
|
DM1KS78
|
Breast cancer [2C60-2C65] |
Talazoparib 0.25 mg capsule |
F24298
|
Tazemetostat
|
DMWP1BH
|
Follicular lymphoma [2A80] |
Tazemetostat 200 mg tablet |
F23299
|
Tofacitinib
|
DMBS370
|
Rheumatoid arthritis [FA20] |
Tofacitinib Citrate eq 22mg base extended release tablet |
F23570
|
Topotecan
|
DMP6G8T
|
Central nervous system neoplasm [] |
Topotecan Hydrochloride eq 0.25mg base capsule |
F23577
|
Trametinib
|
DM2JGQ3
|
Melanoma [2C30] |
Trametinib Dimethyl Sulfoxide eq 2mg tablet |
F23581
|
TRICLABENDAZOLE
|
DMPWGBR
|
Helminth infection [1F90.0] |
Triclabendazole 250 mg tablet |
F23315
|
Upadacitinib
|
DM32B5U
|
Rheumatoid arthritis [FA20] |
Upadacitinib 15 mg Extended-Release tablet |
F23318
|
Vortioxetine
|
DM6F1PU
|
Major depressive disorder [6A70.3] |
Vortioxetine Hydrobromide eq 15mg base tablet |
F23600
|
------------------ |
|
|
|
|